Air Liquide is pursuing the development of its activities in the home healthcare sector and announces the beginning of exclusive negotiations with a view to acquiring 70.49% of LVL Médical Groupe SA’s (LVL Médical) share capital from the controlling shareholders at a price of €30.89 per share.
This transaction, once finalised, would enable Air Liquide to gain control of LVL Médical’s French activities, for an enterprise value of €316million.
This acquisition of a controlling stake in LVL Médical will be followed by a simplified public tender offer (and, possibly, by a compulsory squeeze-out) on the remaining LVL Médical share and subscription warrants, in accordance with applicable rules.
Prior to the acquisition by Air Liquide, LVLMédical’s German activities will be acquired by the Lavorel Family, which is the majority shareholder.
... to continue reading you must be subscribed
